TMCnet News
Market Maker Surveillance Report. DVAX, BSX, MNKD, ALU, AGNC, NEWL, Highest Net Sell Volume and Negative Price Friction For Tuesday, June 18th 2013Jun 19, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3841 companies with "abnormal" market making, 3321 companies with positive Friction Factors and 2007 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Dynavax Technologies Corp (NASDAQ:DVAX), Boston Scientific Corp (NYSE:BSX), Mannkind Corp (NASDAQ:MNKD), Alcatel Lucent SA (NYSE:ALU), American Capital Agency Corp (NASDAQ:AGNC), NewLead Holdings Ltd (NASDAQ:NEWL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction DVAX $-0.050 -4.55% 2,741,218 41.81% 3,815,294 58.19% -1,074,076 -214,815 BSX $-0.090 -0.88% 2,818,619 23.27% 4,214,161 34.79% -1,395,542 -155,060 MNKD $-0.940 -12.47% 18,210,457 47.92% 19,247,945 50.65% -1,037,488 -11,037 ALU $-0.030 -1.58% 3,498,954 27.79% 4,828,374 38.35% -1,329,420 -443,140 AGNC $-0.050 -0.19% 2,907,524 42.63% 3,911,712 57.35% -1,004,188 -200,838 NEWL $-0.070 -25.09% 6,648,625 44.52% 8,286,609 55.48% -1,637,984 -233,998 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent. For example, the chart above shows DVAX down $-0.05000 with a Friction Factor of -214,815 and a Net Volume of -1,074,076. That means that it takes 214,815 more shares of selling than buying to drop DVAX by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction). Dynavax Technologies Corp (NASDAQ:DVAX) - Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. The company's lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. It is also developing Universal Flu vaccine, which is in Phase Ib clinical trial for influenza prevention; DV-601 that is in Phase Ib clinical trial for the treatment of hepatitis B infection; AZD1419, which is in preclinical stage for asthma therapy; and DV1179 that is in Phase I trial for autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize toll-like receptor inhibitors; and research collaboration and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.. Boston Scientific Corp (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.. Mannkind Corp (NASDAQ:MNKD) - MannKind Corporation, a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate, AFREZZA inhalation powder, an ultra rapid-acting insulin therapy that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.. Alcatel Lucent SA (NYSE:ALU) - Alcatel-Lucent, S.A. provides networking and communications technology, products, and services to service providers, enterprises, and governments worldwide. Its Networks segment designs Internet protocol (IP)/multiprotocol label switching service routers, carrier Ethernet service switches, multi-service wide-area-network switches, and content delivery network appliances; designs, manufactures, and markets microwave wireless transmission equipment and optical networking equipment; offers wireless products for 2G, 3G, and 4G networks to mobile operators; and designs and develops IP multimedia subsystem products and IP-based fixed access products. The company s Software, Services and Solutions segment specializes in the consulting, planning, design integration and optimization, and operations management and maintenance of multi-vendor telecommunications networks, as well as in the design, delivery, and operation of network-based software solutions. This segment also develops and sells communication products and solutions that help customers transit to next generation voice, video, and messaging communications services; mobile commerce applications; payment and charging applications, including real-time rating, charging, billing, and payment applications for voice and data services; customer experience applications that enable communication providers to offer, activate, support, and manage a range of high-speed Internet, VoIP, video, mobile, and converged services; an open API platform, which allows developers to collaborate, build, test, and distribute new applications for service provider networks; and CloudBand solution that allows service providers to deliver cloud services to their customers. Alcatel-Lucent, S.A. was formerly known as Alcatel, S.A. and changed its name to Alcatel-Lucent, S.A. in December, 2006. The company was founded in 1898 and is based in Paris, France.. American Capital Agency Corp (NASDAQ:AGNC) - American Capital Agency Corp. operates as a real estate investment trust (REIT). It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by government-sponsored entities or by the United States government agency. The company funds its investments primarily through short-term borrowings structured as repurchase agreements. It has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, the company would not be subject to federal income tax, provided it distributes at least 90% of its taxable income to its shareholders. It is externally managed by American Capital AGNC Management, LLC, which is an affiliate of American Capital, Ltd. American Capital Agency Corp. was founded in 2008 and is based in Bethesda, Maryland.. NewLead Holdings Ltd (NASDAQ:NEWL) - NewLead Holdings Ltd., together with its subsidiaries, engages in the ownership and management of product tankers and dry bulk vessels worldwide. Its tankers transport various refined petroleum products. The company also transports and handles bulk cargoes. As of September 18, 2012, it operated four vessels, including two double-hull product tankers and two dry bulk vessels. The company was formerly known as Aries Maritime Transport Limited and changed its name to NewLead Holdings Ltd. in December 2009. NewLead Holdings Ltd. was incorporated in 2005 and is based in Piraeus, Greece.. About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures. Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected]. |